Ratings by Roth Capital

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/28/2016 Galectin Therapeutics GALT Downgrade Sell
(Buy)
0.75
(N/A)
2.47 1.39 -43.72% Details
9/27/2016 Actinium Pharma ATNM Maintain Buy
(N/A)
5.00
(N/A)
      Details
1,767 more...